Home
About
Overview
Sharing Data
ORCID
Help
History (83)
Behavioral weight loss counseling: Reimbursement policy limits implementation of the evidence
Invariant chain controls the activity of extracellular cathepsin L.
Metipranolol
The alpha 6A beta 1 and alpha 6B beta 1 integrin variants signal differences in the tyrosine phosphorylation of paxillin and other proteins.
BRCA-FA pathway as a target for anti-tumor drugs.
See All 83 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BRCA-FA pathway as a target for anti-tumor drugs.
Litman R, Gupta R, Brosh RM, Cantor SB. BRCA-FA pathway as a target for anti-tumor drugs. Anticancer Agents Med Chem. 2008 May; 8(4):426-30.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
BRCA1 Protein
Cell Line, Tumor
DNA Damage
DNA Repair
Fanconi Anemia Complementation Group Proteins
Humans
Neoplasms
Signal Transduction
authors with profiles
Sharon B Cantor PhD